{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:18Z","timestamp":1786996758507,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.seizure.2021.07.032","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T21:00:21Z","timestamp":1627938021000},"page":"503-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?"],"prefix":"10.1016","volume":"91","author":[{"given":"B\u00e9atrice","family":"Desnous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien","family":"Lenoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Y.","family":"Bitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lina","family":"Arbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Wirrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bello-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel M","family":"Ronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lortie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Birca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.07.032_bib0001","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0387-7604(01)00268-6","article-title":"What is West syndrome?","volume":"23","author":"Dulac","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2021.07.032_bib0002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"C. Response to treatment in a prospective national infantile spasms cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2021.07.032_bib0003","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1528-1167.2012.03623.x","article-title":"A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms","volume":"53","author":"Bitton","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.032_bib0004","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.032_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0887-8994(00)00218-6","article-title":"Steroids or vigabatrin in the treatment of infantile spasms?","volume":"23","author":"Riikonen","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2021.07.032_bib0006","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/epi.12847","article-title":"Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients","volume":"55","author":"Djuric","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.032_bib0007","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1331.2008.02498.x","article-title":"Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin","volume":"16","author":"Cohen-Sadan","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2021.07.032_bib0008","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","article-title":"Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review","volume":"51","author":"Maguire","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.032_bib0009","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.0000000000001069","article-title":"Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study","volume":"83","author":"Westall","year":"2014","journal-title":"Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:04:18Z","timestamp":1761012258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":9,"alternative-id":["S1059131121002673"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.032","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}